Colgate-Palmolive Expected to Post In-Line Q3 Results, UBS Says

MT Newswires Live10-22

Colgate-Palmolive (CL) is expected to post Q3 results on Oct. 30 that are broadly in-line with Street estimates, UBS said in a note Tuesday.

Investor debate is likely to shift to 2027 as inflationary pressures and foreign-exchange headwinds are weighed against topline momentum, UBS said.

Higher input costs make the lower end of the company's 2026 EPS growth range more likely, though UBS expects the company to reiterate guidance rather than make meaningful changes.

Some of the cooling sentiment reflects improving consumption trends at Procter & Gamble (PG), UBS said, while other investors are questioning the trajectory into 2027, including an uneven recovery in North America.

The firm said it understands the pushback, given year-to-date outperformance and a valuation that screens as expensive versus history on a relative basis.

UBS kept the company's buy rating and $106 price target.

Price: 93.64, Change: -0.91, Percent Change: -0.96

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment